Media Focus

Aug 17, 2021

Korean companies eyeing mRNA vaccines to treat cancer

  • Korean companies are actively studying how to use mRNA technology not only to fight Covid-19 but to treat cancer.
  • ST Pharm and Theragen Bio have signed a memorandum of understanding (MOU) to jointly study a “neo-antigen mRNA anticancer vaccine” and cooperation in CDMO (contract development manufacturing organization) business.